If you're new here, have a look at our website. Thanks for visiting!

https://neonatalcare.pediatricsconferences.com/

Recent advances in understanding the pathophysiology and management of cystic fibrosis

Cystic fibrosis (CF) is a life-threatening genetic disease. A child with CF has a faulty gene which affects the movement of sodium chloride in and out of certain cells.

The result is

·         Respiratory symptoms

·         Meconium ileus

·         Failure to thrive

·         Salty tasting skin

·         Lung infections

·         Constipation

·         Greasy and bulky stools

Caucasians have the highest inherited risk for Cystic fibrosis and Asian, Americans have the lowest. Recent high-tech medical advances in drug therapy and genetics are helping children born with CF lead more comfortable lives.
Diagnosis
Sweat tests are generally performed in a lab. A child must have a sodium chloride result of greater than 60 on two separate sweat tests to make the diagnosis of CF.
Several other tests of the routine care used to monitor a child's CF:

• Chest X-rays
• Blood tests to evaluate nutritional status
• Bacterial studies
• Pulmonary function tests (PFTs)

Kids with CF can take oral doses of pancreatic enzymes. They may occasionally need oral or inhaled antibiotics to treat lung infections and mucolytic medication to keep mucus fluid and flowing.

Now get insights into some of the recent advances in diagnosing and managing Cystic fibrosis presented by our humble and fabulous speaker🗣️  Dr. Abeer Mohi El-Din Saleh , Pediatric consultant 👩‍⚕️ from Egypt

Session timings:

Day 1 November 12, 2018

15:20-15:45

22^nd World Congress on Pediatrics, Neonatology & Primary Care

November 12-13, 2018 | Dubai, UAE